Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sedgh, 2016, Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends, Lancet, 388, 258, 10.1016/S0140-6736(16)30380-4
Sedgh, 2014, Intended and unintended pregnancies worldwide in 2012 and recent trends, Stud Fam Plann, 45, 301, 10.1111/j.1728-4465.2014.00393.x
United Nations Department of Economic and Social Affairs Population Division. Trends in contraceptive use worldwide 2015. Available at: http://www.un.org/en/development/desa/population/publications/pdf/family/trendsContraceptiveUse2015Report.pdf. Accessed on 31 December 2017.
Polis, 2016, An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women, AIDS, 30, 2665, 10.1097/QAD.0000000000001228
Hel, 2010, Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection, Endocr Rev, 31, 79, 10.1210/er.2009-0018
Murphy, 2014, Research gaps in defining the biological link between HIV risk and hormonal contraception, Am J Reprod Immunol, 72, 228, 10.1111/aji.12209
Lipsitz R . Women in India get a new birth control option. Available at: http://www.ourbodiesourselves.org/2016/03/women-in-india-get-a-new-birth-control-option/. Accessed on 31 December 2017.
Schivone, 2016, Injectable contraception: updates and innovation, Curr Opin Obstet Gynecol, 28, 504, 10.1097/GCO.0000000000000329
Pfizer. Novel agreement expands access to Pfizer’s contraceptive, Sayana® Press, for women most in need in the world’s poorest countries. Available at: http://www.familyplanning2020.org/articles/4458. Accessed on 31 December 2017.
Whipkey K , DrakeJ, KadeK, BalderstonB. Advocacy pack for subcutaneous DMPA. Available at: https://www.rhsupplies.org/activities-resources/tools/advocacy-pack-for-subcutaneous-dmpa/. Accessed on 31 December 2017.
Joint United Nations Programme on HIV/AIDS (UNAIDS). Fact sheet 2016. Available at: http://www.unaids.org/sites/default/files/media_asset/20150901_FactSheet_2015_en.pdf. Accessed 30 December 2017.
GBD 2015 HIV Collaborators, 2016, Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015, Lancet HIV, 3, e361, 10.1016/S2352-3018(16)30087-X
Avert. HIV around the world. Available at: http://www.avert.org/professionals/hiv-around-world. Accessed 30 December 2017.
UNAIDS. South Africa: HIV and AIDS estimates. Available at: http://www.unaids.org/en/regionscountries/countries/southafrica. Accessed 30 December 2017.
Butler, 2013, Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk, AIDS, 27, 105, 10.1097/QAD.0b013e32835a5a52
Morrison, 2015, Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis, PLoS Med, 12, e1001778, 10.1371/journal.pmed.1001778
Ralph, 2015, Hormonal contraceptive use and women’s risk of HIV acquisition: priorities emerging from recent data, Curr Opin Obstet Gynecol, 27, 487, 10.1097/GCO.0000000000000228
Noguchi, 2015, Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study, Lancet HIV, 2, e279, 10.1016/S2352-3018(15)00058-2
Heffron, 2017, Objective measurement of inaccurate condom use reporting among women using depot medroxyprogesterone acetate for contraception, AIDS Behav, 21, 2173, 10.1007/s10461-016-1563-y
Smith, 2017, Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk, Contraception, 95, 424, 10.1016/j.contraception.2016.12.003
McCoy, 2014, Are hormonal contraceptive users more likely to misreport unprotected sex? Evidence from a biomarker validation study in Zimbabwe, AIDS Behav, 18, 2259, 10.1007/s10461-014-0741-z
World Health Organization. Can women who are at high risk of acquiring HIV, safely use hormonal contraception? Available at: http://www.who.int/reproductivehealth/topics/family_planning/hormonal-contraception-hiv/en/. Accessed 30 December 2017.
ECHO. The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study. Available at: http://echo-consortium.com/. Accessed 30 December 2017.
Stanczyk, 2013, Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects, Endocr Rev, 34, 171, 10.1210/er.2012-1008
Africander, 2011, Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception, Steroids, 76, 636, 10.1016/j.steroids.2011.03.001
Draper BH , MorroniC, HoffmanM, SmitJ, BeksinskaM, HapgoodJ, Van der MerweL. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception. Cochrane Database Syst Rev. 2006; (3):CD005214.
Sitruk-Ware, 2013, Contraception technology: past, present and future, Contraception, 87, 319, 10.1016/j.contraception.2012.08.002
Jacobstein, 2014, Progestin-only contraception: injectables and implants, Best Pract Res Clin Obstet Gynaecol, 28, 795, 10.1016/j.bpobgyn.2014.05.003
Dragoman, 2016, The safety of subcutaneously administered depot medroxyprogesterone acetate (104 mg/0.65 mL): a systematic review, Contraception, 94, 202, 10.1016/j.contraception.2016.02.003
Sitruk-Ware, 2013, Progesterone and related progestins: potential new health benefits, Climacteric, 16, 69, 10.3109/13697137.2013.802556
Hapgood, 2004, Not all progestins are the same: implications for usage, Trends Pharmacol Sci, 25, 554, 10.1016/j.tips.2004.09.005
Stanczyk, 2003, All progestins are not created equal, Steroids, 68, 879, 10.1016/j.steroids.2003.08.003
Polis, 2013, Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches, AIDS, 27, S35, 10.1097/QAD.0000000000000036
Corsini, 1982–1983, Effect of medroxyprogesterone acetate upon PHA, Con A and PWM stimulated lymphocytes and on E-rosette function, J Immunopharmacol, 4, 247, 10.3109/08923978209026438
Mallmann, 1990, Effect of tamoxifen and high-dose medroxyprogesterone acetate (MPA) on cell-mediated immune functions in breast cancer patients, Methods Find Exp Clin Pharmacol, 12, 699
Gillgrass, 2003, Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2, J Virol, 77, 9845, 10.1128/JVI.77.18.9845-9851.2003
Trunova, 2006, Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques, Virology, 352, 169, 10.1016/j.virol.2006.04.004
Kuhl, 2011, Pharmacology of progestogens, J Reproduktionsmed Endokrinol., 8, 157
Kuhl, 2005, Pharmacology of estrogens and progestogens: influence of different routes of administration, Climacteric, 8, 3, 10.1080/13697130500148875
Cherala, 2016, The elusive minimum threshold concentration of levonorgestrel for contraceptive efficacy, Contraception, 94, 104, 10.1016/j.contraception.2016.03.010
Hidalgo, 2009, Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system, Contraception, 80, 84, 10.1016/j.contraception.2009.01.004
Thomas, 2013, A UPLC-MS/MS method for therapeutic drug monitoring of etonogestrel, Ther Drug Monit, 35, 844, 10.1097/FTD.0b013e31829a10fa
Pena, 2012, Randomized, crossover and single-dose bioequivalence study of two oral desogestrel formulations (film-coated tablets of 75 μg) in healthy female volunteers, Sci Pharm, 80, 419, 10.3797/scipharm.1111-18
Shi, 1987, Pharmacokinetics of norethisterone in humans, Contraception, 35, 465, 10.1016/0010-7824(87)90083-7
Smit, 2004, Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval, Contraception, 69, 3, 10.1016/j.contraception.2003.09.005
U.S. Food and Drug Administration. Depo-SubQ Provera 104 (medroxyprogesterone acetate) injectable suspension. New drug application no. 021583. Center for Drug Evaluation and Research clinical pharmacology and biopharmaceutics review. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021584s000_depo-subQTOC.cfm. Accessed 31 December 2017.
Mathrubutham, 1981, Medroxyprogesterone acetate in human serum, J Steroid Biochem, 14, 783, 10.1016/0022-4731(81)90015-7
Kirton, 1974, Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera), Contraception, 10, 39, 10.1016/0010-7824(74)90130-9
Jeppsson, 1976, Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of Depo-Provera to women, Contraception, 14, 461, 10.1016/S0010-7824(76)80060-1
Koetsawang, 1977, Injected long-acting medroxyprogesterone acetate. Effect on human lactation and concentrations in milk, J Med Assoc Thai, 60, 57
Shrimanker, 1978, A radioimmunoassay for serum medroxyprogesterone acetate, J Steroid Biochem, 9, 359, 10.1016/0022-4731(78)90631-3
Fotherby, 1980, A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate, Fertil Steril, 34, 131, 10.1016/S0015-0282(16)44895-8
Fotherby, 1980, Pharmacokinetic study of different doses of Depo Provera, Contraception, 22, 527, 10.1016/0010-7824(80)90105-5
Jeppsson, 1982, Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent, Acta Endocrinol (Copenh), 99, 339, 10.1530/acta.0.0990339
Fang, 2004, Concentration changes if medroxyprogesterone acetate in serum and milk in lactating women who used depo geston, J Reprod Contraception., 15, 157
Bonny, 2014, A pilot study of depot medroxyprogesterone acetate pharmacokinetics and weight gain in adolescent females, Contraception, 89, 357, 10.1016/j.contraception.2014.01.017
Nanda, 2016, Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial, Contraception, 94, 40, 10.1016/j.contraception.2016.03.003
Ortiz, 1977, Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA, J Clin Endocrinol Metab, 44, 32, 10.1210/jcem-44-1-32
Virutamasen, 1996, Pharmacodynamic effects of depot-medroxyprogesterone acetate (DMPA) administered to lactating women on their male infants, Contraception, 54, 153, 10.1016/S0010-7824(96)00170-9
Mishell, 1996, Pharmacokinetics of depot medroxyprogesterone acetate contraception, J Reprod Med, 41, 381
Kaunitz, 2009, Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density, Contraception, 80, 7, 10.1016/j.contraception.2009.02.005
Jain, 2004, Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera, Contraception, 70, 11, 10.1016/j.contraception.2004.01.011
Toh, 2004, Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg/0.65 mL) contraceptive formulation in Asian women, Clin Ther, 26, 1845, 10.1016/j.clinthera.2004.11.013
Halpern, 2014, Pharmacokinetics of subcutaneous depot medroxyprogesterone acetate injected in the upper arm, Contraception, 89, 31, 10.1016/j.contraception.2013.07.002
Selim, 2013, Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS), Contraception, 87, 396, 10.1016/j.contraception.2012.12.008
Sivin, 1997, Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants, Contraception, 55, 81, 10.1016/S0010-7824(96)00276-4
Licea-Perez, 2007, A semi-automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci, 852, 69, 10.1016/j.jchromb.2006.12.052
Fotherby, 1982, Metabolism of injectable formulations of contraceptive steroids in obese and thin women, Contraception, 26, 51, 10.1016/0010-7824(82)90171-8
Sang, 1981, Pharmacokinetics of norethisterone oenanthate in humans, Contraception, 24, 15, 10.1016/0010-7824(81)90065-2
Goebelsmann, 1979, Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone, Contraception, 19, 283, 10.1016/0010-7824(79)90022-2
Wenzl, 1998, Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon, Contraception, 58, 283, 10.1016/S0010-7824(98)00110-3
Mornar, 2012, Pharmacokinetics of the etonogestrel contraceptive implant in obese women, Am J Obstet Gynecol, 207, 110.e1-6, 10.1016/j.ajog.2012.05.002
Kuhnz, 1992, Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations, Arzneimittelforschung, 42, 1139
Nanda, 2008, Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy, Fertil Steril, 90, 965, 10.1016/j.fertnstert.2007.07.1348
Kärkkäinen, 1990, Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer, Eur J Cancer, 26, 975, 10.1016/0277-5379(90)90624-3
Keefe, 2014, Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry, PLoS One, 9, e93805, 10.1371/journal.pone.0093805
Mould, 1989, A comparison of the high-performance liquid chromatography and RIA measurement of medroxyprogesterone acetate, J Pharm Biomed Anal, 7, 119, 10.1016/0731-7085(89)80072-X
Canney, 1988, The pharmacokinetics of medroxyprogesterone acetate following two different loading dose schedules in advanced carcinoma of the breast, Br J Cancer, 58, 73, 10.1038/bjc.1988.165
Miller, 1988, Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer, J Cancer Res Clin Oncol, 114, 186, 10.1007/BF00417835
Scambia, 1988, Effects of antiestrogen and progestin on immune functions in breast cancer patients, Cancer, 61, 2214, 10.1002/1097-0142(19880601)61:11<2214::AID-CNCR2820611115>3.0.CO;2-V
Yamashita, 1996, Medroxyprogesterone acetate treatment reduces serum interleukin-6 levels in patients with metastatic breast carcinoma, Cancer, 78, 2346, 10.1002/(SICI)1097-0142(19961201)78:11<2346::AID-CNCR12>3.0.CO;2-0
Vesterinen, 1981, Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma, Arch Gynecol, 230, 205, 10.1007/BF02111804
Hedley, 1985, Lack of correlations between plasma concentration of medroxyprogesterone acetate, hypothalamic-pituitary function, and tumour response in patients with advanced breast cancer, Cancer Chemother Pharmacol, 14, 112, 10.1007/BF00434347
Polis, 2016, Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals, AIDS, 30, 2571, 10.1097/QAD.0000000000001229
Thurman, 2016, Comparison of follicular and luteal phase mucosal markers of HIV susceptibility in healthy women, AIDS Res Hum Retroviruses, 32, 547, 10.1089/aid.2015.0264
Hafner, 2013, Ovarian steroid hormones: effects on immune responses and Chlamydia trachomatis infections of the female genital tract, Mucosal Immunol, 6, 859, 10.1038/mi.2013.46
Altemus, 1997, Reduced sensitivity to glucocorticoid feedback and reduced glucocorticoid receptor mRNA expression in the luteal phase of the menstrual cycle, Neuropsychopharmacology, 17, 100
Hapgood, 2014, Potency of progestogens used in hormonal therapy: toward understanding differential actions, J Steroid Biochem Mol Biol, 142, 39, 10.1016/j.jsbmb.2013.08.001
Hapgood, 2016, Glucocorticoid-independent modulation of GR activity: implications for immunotherapy, Pharmacol Ther, 165, 93, 10.1016/j.pharmthera.2016.06.002
Bennesch, 2015, Minireview: tipping the balance: ligand-independent activation of steroid receptors, Mol Endocrinol, 29, 349, 10.1210/me.2014-1315
Levin, 2016, Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors, Nat Rev Mol Cell Biol, 17, 783, 10.1038/nrm.2016.122
Cruz-Topete, 2015, One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids, Neuroimmunomodulation, 22, 20, 10.1159/000362724
Mohammed, 2015, Progesterone receptor modulates ERα action in breast cancer, Nature, 523, 313, 10.1038/nature14583
Dahm, 2012, A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women, Thromb Res, 130, 45, 10.1016/j.thromres.2011.12.009
Kayisli, 2015, Long-acting progestin-only contraceptives impair endometrial vasculature by inhibiting uterine vascular smooth muscle cell survival, Proc Natl Acad Sci USA, 112, 5153, 10.1073/pnas.1424814112
Guzeloglu Kayisli, 2015, Progestins upregulate FKBP51 expression in human endometrial stromal cells to induce functional progesterone and glucocorticoid withdrawal: implications for contraceptive-associated abnormal uterine bleeding, PLoS One, 10, e0137855, 10.1371/journal.pone.0137855
Ghatge, 2005, The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells, Breast Cancer Res, 7, R1036, 10.1186/bcr1340
Lei, 2012, Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1β-induced COX-2 expression in human term myometrial cells, PLoS One, 7, e50167, 10.1371/journal.pone.0050167
Tan, 2012, Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: implications for progesterone actions in human pregnancy and parturition, J Clin Endocrinol Metab, 97, E719, 10.1210/jc.2011-3251
Ronacher, 2009, Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction, Mol Cell Endocrinol, 299, 219, 10.1016/j.mce.2008.10.008
Africander, 2013, Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy, Biochem Biophys Res Commun, 433, 305, 10.1016/j.bbrc.2013.02.086
Africander, 2014, A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A), J Steroid Biochem Mol Biol, 143, 404, 10.1016/j.jsbmb.2014.05.007
Koubovec, 2005, Synthetic progestins used in HRT have different glucocorticoid agonist properties, Mol Cell Endocrinol, 242, 23, 10.1016/j.mce.2005.07.001
Koubovec, 2004, Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells, Mol Cell Endocrinol, 221, 75, 10.1016/j.mce.2004.03.006
Chu, 2007, Formation of ethinyl estradiol in women during treatment with norethindrone acetate, J Clin Endocrinol Metab, 92, 2205, 10.1210/jc.2007-0044
Kuhl, 2007, Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications, Climacteric, 10, 344, 10.1080/13697130701380434
Chwalisz, 2012, The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis, Reprod Sci, 19, 563, 10.1177/1933719112438061
Kuhnz, 1997, In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women, Contraception, 56, 379, 10.1016/S0010-7824(97)00174-1
Louw-du Toit, 2014, Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner, J Biol Chem, 289, 31136, 10.1074/jbc.M114.587311
Giannoukos, 2001, New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties, Mol Endocrinol, 15, 255, 10.1210/mend.15.2.0596
Sasagawa, 2008, Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile, Steroids, 73, 222, 10.1016/j.steroids.2007.10.003
Kleynhans, 2011, Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users, PLoS One, 6, e24639, 10.1371/journal.pone.0024639
Chow, 2011, Inferring mechanisms from dose-response curves, Methods Enzymol, 487, 465, 10.1016/B978-0-12-381270-4.00016-0
Bamberger, 1999, Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes, J Clin Endocrinol Metab, 84, 4055
Govender, 2014, The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor, PLoS One, 9, e96497, 10.1371/journal.pone.0096497
Zhao, 2003, Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression, Int Immunopharmacol, 3, 1803, 10.1016/j.intimp.2003.08.005
Robertson, 2013, Impact of glucocorticoid receptor density on ligand-independent dimerization, cooperative ligand-binding and basal priming of transactivation: a cell culture model, PLoS One, 8, e64831, 10.1371/journal.pone.0064831
Bray, 2005, Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells, J Steroid Biochem Mol Biol, 97, 328, 10.1016/j.jsbmb.2005.06.032
Beasley, 2014, Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate, Contraception, 89, 352, 10.1016/j.contraception.2014.01.026
Fuhrmann, 1995, Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays, Contraception, 51, 45, 10.1016/0010-7824(94)00003-F
Kontula, 1983, Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes, Biochem Pharmacol, 32, 1511, 10.1016/0006-2952(83)90474-4
Huijbregts, 2013, Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms, Endocrinology, 154, 1282, 10.1210/en.2012-1850
Hapgood, 2014, Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis, Am J Reprod Immunol, 71, 505, 10.1111/aji.12214
Irvin, 2015, Molecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk, PLoS One, 10, e0121135, 10.1371/journal.pone.0121135
Hapgood, 2013, Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate, Endocrinology, 154, 985, 10.1210/en.2013-1066
Huijbregts, 2014, Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs, Contraception, 90, 123, 10.1016/j.contraception.2014.02.006
Quispe Calla, 2015, Medroxyprogesterone acetate impairs human dendritic cell activation and function, Hum Reprod, 30, 1169, 10.1093/humrep/dev035
Tomasicchio, 2013, The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor, PLoS One, 8, e62895, 10.1371/journal.pone.0062895
Sampah, 2015, Medroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro, AIDS, 29, 1137, 10.1097/QAD.0000000000000681
Ferreira, 2015, Medroxyprogesterone acetate regulates HIV-1 uptake and transcytosis but not replication in primary genital epithelial cells, resulting in enhanced T-cell infection, J Infect Dis, 211, 1745, 10.1093/infdis/jiu832
Kleynhans, 2013, The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis, Infect Immun, 81, 1234, 10.1128/IAI.01189-12
Vicetti Miguel, 2012, Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection, J Immunol, 189, 3449, 10.4049/jimmunol.1103054
Quispe Calla, 2016, Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection, Mucosal Immunol, 9, 1571, 10.1038/mi.2016.22
Radzio, 2014, Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques, AIDS, 28, 1431, 10.1097/QAD.0000000000000294
Butler, 2016, A depot medroxyprogesterone acetate dose that models human use and its effect on vaginal SHIV acquisition risk, J Acquir Immune Defic Syndr, 72, 363, 10.1097/QAI.0000000000000975
Baschant, 2010, The role of the glucocorticoid receptor in inflammation and immunity, J Steroid Biochem Mol Biol, 120, 69, 10.1016/j.jsbmb.2010.03.058
Chinenov, 2014, Glucocorticoid receptor coordinates transcription factor-dominated regulatory network in macrophages, BMC Genomics, 15, 656, 10.1186/1471-2164-15-656
Chinenov, 2013, Nuclear receptors in inflammation control: repression by GR and beyond, Mol Cell Endocrinol, 380, 55, 10.1016/j.mce.2013.04.006
Busillo, 2013, The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore, Trends Endocrinol Metab, 24, 109, 10.1016/j.tem.2012.11.005
Frenkel, 2015, Glucocorticoid-induced osteoporosis, Adv Exp Med Biol, 872, 179, 10.1007/978-1-4939-2895-8_8
Padgett, 2003, How stress influences the immune response, Trends Immunol, 24, 444, 10.1016/S1471-4906(03)00173-X
Ng, 2013, Viral infection increases glucocorticoid-induced interleukin-10 production through ERK-mediated phosphorylation of the glucocorticoid receptor in dendritic cells: potential clinical implications, PLoS One, 8, e63587, 10.1371/journal.pone.0063587
Hapgood, 2010, Modulation of HIV-1 virulence via the host glucocorticoid receptor: towards further understanding the molecular mechanisms of HIV-1 pathogenesis, Arch Virol, 155, 1009, 10.1007/s00705-010-0678-0
Quispe Calla, 2016, Dendritic cell function and pathogen-specific T cell immunity are inhibited in mice administered levonorgestrel prior to intranasal Chlamydia trachomatis infection, Sci Rep, 6, 37723, 10.1038/srep37723
Ferreira, 2010, Should the human microbiome be considered when developing vaccines, PLoS Pathog, 6, e1001190, 10.1371/journal.ppat.1001190
Sciaranghella, 2015, CCR5 expression levels in HIV-uninfected women receiving hormonal contraception, J Infect Dis, 212, 1397, 10.1093/infdis/jiv233
Chandra, 2013, Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues, AIDS Res Hum Retroviruses, 29, 592, 10.1089/aid.2012.0271
Prakash, 2002, Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4+ T cells in the cervical epithelium of healthy women, J Reprod Immunol, 54, 117, 10.1016/S0165-0378(01)00125-5
Byrne, 2016, Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study, Lancet Infect Dis, 16, 441, 10.1016/S1473-3099(15)00429-6
Achilles, 2014, Changes in genital tract immune cell populations after initiation of intrauterine contraception, Am J Obstet Gynecol, 211, 489.e1-9, 10.1016/j.ajog.2014.05.016
Smith-McCune, 2017, Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility, Mucosal Immunol, 10, 1270, 10.1038/mi.2016.121
Michel, 2015, Effect of hormonal contraception on the function of plasmacytoid dendritic cells and distribution of immune cell populations in the female reproductive tract, J Acquir Immune Defic Syndr, 68, 511, 10.1097/QAI.0000000000000531
Hughes, 2008, Cutting edge: progesterone regulates IFN-α production by plasmacytoid dendritic cells, J Immunol, 180, 2029, 10.4049/jimmunol.180.4.2029
Miller, 2000, Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium, Obstet Gynecol, 96, 431
Bahamondes, 2014, Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate, Contraception, 90, 117, 10.1016/j.contraception.2014.01.024
Mauck, 1999, The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy, Contraception, 60, 15, 10.1016/S0010-7824(99)00058-X
Bahamondes, 2000, The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera, Contraception, 62, 23, 10.1016/S0010-7824(00)00132-3
Morrison, 2014, Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion, J Acquir Immune Defic Syndr, 66, 109, 10.1097/QAI.0000000000000103
Fichorova, 2015, The contribution of cervicovaginal infections to the immunomodulatory effects of hormonal contraception, MBio, 6, e00221-15, 10.1128/mBio.00221-15
Li, 2008, Effect of mifepristone on the expression of endometrial secretory leukocyte protease inhibitor in new medroxyprogesterone acetate users, Fertil Steril, 90, 872, 10.1016/j.fertnstert.2007.01.046
Deese, 2015, Injectable progestin-only contraception is associated with increased levels of pro-inflammatory cytokines in the female genital tract, Am J Reprod Immunol, 74, 357, 10.1111/aji.12415
Francis, 2016, Immune activation in the female genital tract: expression profiles of soluble proteins in women at high risk for HIV infection, PLoS One, 11, e0143109, 10.1371/journal.pone.0143109
Roxby, 2016, Changes in vaginal microbiota and immune mediators in HIV-1-seronegative Kenyan women initiating depot medroxyprogesterone acetate, J Acquir Immune Defic Syndr, 71, 359, 10.1097/QAI.0000000000000866
Fleming, 2003, Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium, Fertil Steril, 79, 856, 10.1016/S0015-0282(02)04930-0
Goldfien, 2015, Progestin-containing contraceptives alter expression of host defense-related genes of the endometrium and cervix, Reprod Sci, 22, 814, 10.1177/1933719114565035
Ngcapu, 2015, Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive, J Reprod Immunol, 110, 14, 10.1016/j.jri.2015.03.007
Abel, 2004, Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of Depo-Provera before intravaginal challenge with simian immunodeficiency virus mac239, J Infect Dis, 190, 1697, 10.1086/424600
Genescà, 2007, Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239, J Med Primatol, 36, 266, 10.1111/j.1600-0684.2007.00244.x
Hild-Petito, 1998, Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys, AIDS Res Hum Retroviruses, 14, S125
Butler, 2015, Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques, J Med Primatol, 44, 286, 10.1111/jmp.12188
Kaushic, 2003, Progesterone increases susceptibility and decreases immune responses to genital herpes infection, J Virol, 77, 4558, 10.1128/JVI.77.8.4558-4565.2003
Dietz Ostergaard, 2015, A combined oral contraceptive affects mucosal SHIV susceptibility factors in a pigtail macaque (Macaca nemestrina) model, J Med Primatol, 44, 97, 10.1111/jmp.12157
Goode, 2014, Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmission, PLoS One, 9, e97767, 10.1371/journal.pone.0097767
Deligdisch, 2000, Hormonal pathology of the endometrium, Mod Pathol, 13, 285, 10.1038/modpathol.3880050
Dinh, 2015, A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women, Contraception, 91, 360, 10.1016/j.contraception.2015.01.008
Farage, 2006, Lifetime changes in the vulva and vagina, Arch Gynecol Obstet, 273, 195, 10.1007/s00404-005-0079-x
Jacobson, 2000, Histologic development of cervical ectopy: relationship to reproductive hormones, Sex Transm Dis, 27, 252, 10.1097/00007435-200005000-00003
Noyes, 1973, The Uterus, 110
Brenner, 1975, Hormonal regulation of the reproductive tract in female mammals, Annu Rev Physiol, 37, 273, 10.1146/annurev.ph.37.030175.001421
Ferenczy, 1979, Proliferation kinetics of human endometrium during the normal menstrual cycle, Am J Obstet Gynecol, 133, 859, 10.1016/0002-9378(79)90302-8
Moyer, 1998, The effects of progesterone and progestins on endometrial proliferation, Contraception, 57, 399, 10.1016/S0010-7824(98)00047-X
Bergeron, 2000, Morphological changes and protein secretion induced by progesterone in the endometrium during the luteal phase in preparation for nidation, Hum Reprod, 15, 119, 10.1093/humrep/15.suppl_1.119
Nonogaki, 1990, Estrogen receptor localization in normal and neoplastic epithelium of the uterine cervix, Cancer, 66, 2620, 10.1002/1097-0142(19901215)66:12<2620::AID-CNCR2820661226>3.0.CO;2-S
Konishi, 1991, Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix, Cancer, 68, 1340, 10.1002/1097-0142(19910915)68:6<1340::AID-CNCR2820680626>3.0.CO;2-Q
Sanborn, 1976, Hormonal action in human cervix—II. Specific progestogen binding proteins in human cervix, J Steroid Biochem, 7, 665, 10.1016/0022-4731(76)90063-7
Singer, 1975, The uterine cervix from adolescence to the menopause, Br J Obstet Gynaecol, 82, 81, 10.1111/j.1471-0528.1975.tb02204.x
Jacobson, 1999, Cervical ectopy and the transformation zone measured by computerized planimetry in adolescents, Int J Gynaecol Obstet, 66, 7, 10.1016/S0020-7292(99)00037-5
Mostad, 1999, Prevalence and correlates of HIV type 1 shedding in the female genital tract, AIDS Res Hum Retroviruses, 14, S11
Kyongo, 2015, Cross-sectional analysis of selected genital tract immunological markers and molecular vaginal microbiota in sub-Saharan African women, with relevance to HIV risk and prevention, Clin Vaccine Immunol, 22, 526, 10.1128/CVI.00762-14
Myer, 2006, Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa, Sex Transm Dis, 33, 683, 10.1097/01.olq.0000216026.67352.f9
Tanton, 2011, Correlates of HIV-1 genital shedding in Tanzanian women, PLoS One, 6, e17480, 10.1371/journal.pone.0017480
Buchanan, 1998, Role of stromal and epithelial estrogen receptors in vaginal epithelial proliferation, stratification, and cornification, Endocrinology, 139, 4345, 10.1210/endo.139.10.6241
Patton, 2000, Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle, Am J Obstet Gynecol, 183, 967, 10.1067/mob.2000.108857
Gebhart, 2001, Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women, Am J Obstet Gynecol, 185, 1325, 10.1067/mob.2001.119627
Anderson, 2014, The structure of the human vaginal stratum corneum and its role in immune defense, Am J Reprod Immunol, 71, 618, 10.1111/aji.12230
Nilsson, 1995, The vaginal epithelium in the postmenopause—cytology, histology and pH as methods of assessment, Maturitas, 21, 51, 10.1016/0378-5122(94)00863-3
Hickey, 2011, Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections, J Reprod Immunol, 88, 185, 10.1016/j.jri.2011.01.005
Wira, 2008, A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle, AIDS, 22, 1909, 10.1097/QAD.0b013e3283060ea4
Wira, 2005, Innate and adaptive immunity in female genital tract: cellular responses and interactions, Immunol Rev, 206, 306, 10.1111/j.0105-2896.2005.00287.x
Kaushic, 2011, Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses, J Reprod Immunol, 88, 204, 10.1016/j.jri.2010.12.004
Gray, 2005, Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study, Lancet, 366, 1182, 10.1016/S0140-6736(05)67481-8
Mugo, 2011, Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples, AIDS, 25, 1887, 10.1097/QAD.0b013e32834a9338
Coakley, 2005, Assessing chemokine co-receptor usage in HIV, Curr Opin Infect Dis, 18, 9, 10.1097/00001432-200502000-00003
Keele, 2008, Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection, Proc Natl Acad Sci USA, 105, 7552, 10.1073/pnas.0802203105
Selhorst, 2017, Cervicovaginal inflammation facilitates acquisition of less infectious HIV variants, Clin Infect Dis, 64, 79, 10.1093/cid/ciw663
Haynes, 2016, HIV-host interactions: implications for vaccine design, Cell Host Microbe, 19, 292, 10.1016/j.chom.2016.02.002
Douek, 2009, Emerging concepts in the immunopathogenesis of AIDS, Annu Rev Med, 60, 471, 10.1146/annurev.med.60.041807.123549
Meditz, 2011, HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo, J Virol, 85, 10189, 10.1128/JVI.02529-10
Micci, 2014, CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells, PLoS Pathog, 10, e1004467, 10.1371/journal.ppat.1004467
Hladik, 2007, Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1, Immunity, 26, 257, 10.1016/j.immuni.2007.01.007
Sagar, 2014, Origin of the transmitted virus in HIV infection: infected cells versus cell-free virus, J Infect Dis, 210, S667, 10.1093/infdis/jiu369
Hel, 2006, HIV infection: first battle decides the war, Trends Immunol, 27, 274, 10.1016/j.it.2006.04.007
Anderson, 2014, Cell-associated HIV mucosal transmission: the neglected pathway, J Infect Dis, 210, S606, 10.1093/infdis/jiu538
Kell, 1992, HIV infection in a patient with Meyer-Rokitansky-Küster-Hauser syndrome, J R Soc Med, 85, 706, 10.1177/014107689208501119
Miller, 1992, Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques, J Med Primatol, 21, 64, 10.1111/j.1600-0684.1992.tb00569.x
Ferreira, 2014, Influence of common mucosal co-factors on HIV infection in the female genital tract, Am J Reprod Immunol, 71, 543, 10.1111/aji.12221
Stieh, 2014, Vaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tract, PLoS Pathog, 10, e1004440, 10.1371/journal.ppat.1004440
Mishell, 1972, Estrogenic activity in women receiving an injectable progestogen for contraception, Am J Obstet Gynecol, 113, 372, 10.1016/0002-9378(72)90687-4
Hickey, 2016, Critical review: mechanisms of HIV transmission in Depo-Provera users: the likely role of hypoestrogenism, J Acquir Immune Defic Syndr, 71, 1, 10.1097/QAI.0000000000000805
Anipindi, 2016, Estradiol enhances CD4+ T-cell anti-viral immunity by priming vaginal DCs to induce Th17 responses via an IL-1-dependent pathway, PLoS Pathog, 12, e1005589, 10.1371/journal.ppat.1005589
Wira, 2014, Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens, Am J Reprod Immunol, 72, 236, 10.1111/aji.12252
Marx, 1996, Progesterone implants enhance SIV vaginal transmission and early virus load, Nat Med, 2, 1084, 10.1038/nm1096-1084
Smith, 2000, Estrogen protects against vaginal transmission of simian immunodeficiency virus, J Infect Dis, 182, 708, 10.1086/315776
Hummelen, 2011, Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness, PLoS One, 6, e26602, 10.1371/journal.pone.0026602
Cotreau, 2007, A study of 17β-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy, Maturitas, 58, 366, 10.1016/j.maturitas.2007.09.009
Smith, 2004, Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect, AIDS, 18, 1637, 10.1097/01.aids.0000131393.76221.cc
Gillgrass, 2005, Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation, J Virol, 79, 3107, 10.1128/JVI.79.5.3107-3116.2005
Bhavanam, 2008, Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone, Vaccine, 26, 6165, 10.1016/j.vaccine.2008.08.045
Mestecky, 2009, Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection, J Reprod Immunol, 83, 196, 10.1016/j.jri.2009.07.005
Molander, 1990, Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause, Maturitas, 12, 113, 10.1016/0378-5122(90)90089-O
Smith, 1993, Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring, Acta Obstet Gynecol Scand Suppl, 157, 1
Castelo-Branco, 2005, Management of post-menopausal vaginal atrophy and atrophic vaginitis, Maturitas, 52, S46, 10.1016/j.maturitas.2005.06.014
Wieser, 2001, Progesterone increases the number of Langerhans cells in human vaginal epithelium, Fertil Steril, 75, 1234, 10.1016/S0015-0282(01)01796-4
Klebanoff, 1991, Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission, J Exp Med, 174, 289, 10.1084/jem.174.1.289
Martin, 1999, Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition, J Infect Dis, 180, 1863, 10.1086/315127
Taha, 1998, Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV, AIDS, 12, 1699, 10.1097/00002030-199813000-00019
Atashili, 2008, Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies, AIDS, 22, 1493, 10.1097/QAD.0b013e3283021a37
Sanders-Beer, 2010, Depo-Provera does not alter disease progression in SIVmac-infected female Chinese rhesus macaques, AIDS Res Hum Retroviruses, 26, 433, 10.1089/aid.2009.0185
Sodora, 1998, Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks, AIDS Res Hum Retroviruses, 14, S119
Vishwanathan, 2011, High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques, J Acquir Immune Defic Syndr, 57, 261, 10.1097/QAI.0b013e318220ebd3
Poonia, 2006, Cyclic changes in the vaginal epithelium of normal rhesus macaques, J Endocrinol, 190, 829, 10.1677/joe.1.06873
Mora, 1976, Plasma levels of medroxyprogesterone acetate (MPA), estradiol and progesterone in the rhesus monkey after intramuscular adminstration of Depo-Provera, Contraception, 14, 343, 10.1016/0010-7824(76)90101-3
Kersh, 2015, Relationship of estimated SHIV acquisition time points during the menstrual cycle and thinning of vaginal epithelial layers in pigtail macaques, Sex Transm Dis, 42, 694, 10.1097/OLQ.0000000000000367
Parr, 1994, A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2, Lab Invest, 70, 369
World Health Organization . Global incidence and prevalence of selected curable sexually transmitted infections—2008. Available at: http://apps.who.int/iris/handle/10665/75181. Accessed 31 December 2017.
World Health Organization . Sexually transmitted infections (STIs). Available at: http://www.who.int/mediacentre/factsheets/fs110/en/. Accessed 31 December 2017.
Looker, 2008, An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection, Bull World Health Organ, 86, 805, 10.2471/BLT.07.046128
Sexton, 2005, Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection, Sex Transm Dis, 32, 351, 10.1097/01.olq.0000154504.54686.d1
Ward, 2010, Contribution of sexually transmitted infections to the sexual transmission of HIV, Curr Opin HIV AIDS, 5, 305, 10.1097/COH.0b013e32833a8844
Alkema, 2013, National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis, Lancet, 381, 1642, 10.1016/S0140-6736(12)62204-1
Darroch, 2013, Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys, Lancet, 381, 1756, 10.1016/S0140-6736(13)60597-8
Morrison, 2009, Highly effective contraception and acquisition of HIV and other sexually transmitted infections, Best Pract Res Clin Obstet Gynaecol, 23, 263, 10.1016/j.bpobgyn.2008.11.004
Mohllajee, 2006, Hormonal contraceptive use and risk of sexually transmitted infections: a systematic review, Contraception, 73, 154, 10.1016/j.contraception.2005.08.012
Venkatesh, 2013, Assessing the relationship between cervical ectopy and HIV susceptibility: implications for HIV prevention in women, Am J Reprod Immunol, 69, 68, 10.1111/aji.12029
Roura, 2016, The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort, PLoS One, 11, e0147029, 10.1371/journal.pone.0147029
Grabowski, 2015, Use of injectable hormonal contraception and women’s risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda, Lancet Glob Health, 3, e478, 10.1016/S2214-109X(15)00086-8
Kaushic, 2011, HIV-1 infection in the female reproductive tract: role of interactions between HIV-1 and genital epithelial cells, Am J Reprod Immunol, 65, 253, 10.1111/j.1600-0897.2010.00965.x
Morris, 2015, Relationship of menstrual cycle and vaginal infection in female rhesus macaques challenged with repeated, low doses of SIVmac251, J Med Primatol, 44, 301, 10.1111/jmp.12177
McNicholl, 2014, Non-human primate models of hormonal contraception and HIV, Am J Reprod Immunol, 71, 513, 10.1111/aji.12246
Jerse, 2011, Estradiol-treated female mice as surrogate hosts for Neisseria gonorrhoeae genital tract infections, Front Microbiol, 2, 107, 10.3389/fmicb.2011.00107
van de Wijgert, 2013, Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission, AIDS, 27, 2141, 10.1097/QAD.0b013e32836290b6
Gilliet, 2008, Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases, Nat Rev Immunol, 8, 594, 10.1038/nri2358
Siegal, 1999, The nature of the principal type 1 interferon-producing cells in human blood, Science, 284, 1835, 10.1126/science.284.5421.1835
Li, 2009, Glycerol monolaurate prevents mucosal SIV transmission, Nature, 458, 1034, 10.1038/nature07831
Ballweber, 2011, Vaginal Langerhans cells nonproductively transporting HIV-1 mediate infection of T cells, J Virol, 85, 13443, 10.1128/JVI.05615-11
van den Berg, 2014, Caveolin-1 mediated uptake via langerin restricts HIV-1 infection in human Langerhans cells, Retrovirology, 11, 123, 10.1186/s12977-014-0123-7
Mayr, 2017, Langerhans cells: the “yin and yang” of HIV restriction and transmission, Trends Microbiol, 25, 170, 10.1016/j.tim.2017.01.009
Ildgruben, 2003, Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium, Obstet Gynecol, 102, 571
Cherpes, 2008, Medroxyprogesterone acetate inhibits CD8+ T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation, J Immunol, 181, 969, 10.4049/jimmunol.181.2.969
Schindler, 2003, Classification and pharmacology of progestins, Maturitas, 46, S7, 10.1016/j.maturitas.2003.09.014
Herold, 2006, Glucocorticoids in T cell apoptosis and function, Cell Mol Life Sci, 63, 60, 10.1007/s00018-005-5390-y
Zhou, 2005, The human glucocorticoid receptor: one gene, multiple proteins and diverse responses, Steroids, 70, 407, 10.1016/j.steroids.2005.02.006
Kino, 2003, Tissue glucocorticoid resistance/hypersensitivity syndromes, J Steroid Biochem Mol Biol, 85, 457, 10.1016/S0960-0760(03)00218-8
Mirani, 2002, HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection, J Immunol, 169, 6361, 10.4049/jimmunol.169.11.6361
Ghosh, 1992, Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat, J Virol, 66, 586, 10.1128/JVI.66.1.586-590.1992
Kolesnitchenko, 1992, Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormone stimulation, AIDS Res Hum Retroviruses, 8, 1977, 10.1089/aid.1992.8.1977
Mitra, 1995, Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression, Virology, 214, 512, 10.1006/viro.1995.0062
Kino, 2000, Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology, J Steroid Biochem Mol Biol, 75, 283, 10.1016/S0960-0760(00)00187-4
Markham, 1985, Advances in the isolation of HTLV-III from patients with AIDS and AIDS-related complex and from donors at risk, Cancer Res, 45, 4588s
Markham, 1986, Hydrocortisone and some other hormones enhance the expression of HTLV-III, Int J Cancer, 37, 67, 10.1002/ijc.2910370112
Soudeyns, 1993, Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1, Virology, 194, 758, 10.1006/viro.1993.1317
Wiegers, 2008, Activation of the glucocorticoid receptor releases unstimulated PBMCs from an early block in HIV-1 replication, Virology, 375, 73, 10.1016/j.virol.2008.01.037
Sheffield, 2009, The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression, Reprod Sci, 16, 20, 10.1177/1933719108325510
Cabrera-Muñoz, 2012, Effects of progesterone on the content of CCR5 and CXCR4 coreceptors in PBMCs of seropositive and exposed but uninfected Mexican women to HIV-1, J Steroid Biochem Mol Biol, 132, 66, 10.1016/j.jsbmb.2012.02.001
Straub, 2007, The complex role of estrogens in inflammation, Endocr Rev, 28, 521, 10.1210/er.2007-0001
Mitchell, 2014, Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells, J Infect Dis, 210, 651, 10.1093/infdis/jiu176
Byrareddy, 2014, Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection, Nat Med, 20, 1397, 10.1038/nm.3715
Stieh, 2016, Th17 cells are preferentially infected very early after vaginal transmission of SIV in macaques, Cell Host Microbe, 19, 529, 10.1016/j.chom.2016.03.005
Cecchinato, 2008, Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques, Mucosal Immunol, 1, 279, 10.1038/mi.2008.14
Xu, 2013, Progesterone suppresses Th17 cell responses, and enhances the development of regulatory T cells, through thymic stromal lymphopoietin-dependent mechanisms in experimental gonococcal genital tract infection, Microbes Infect, 15, 796, 10.1016/j.micinf.2013.06.012
Semple, 2012, β-Defensins: multifunctional modulators of infection, inflammation and more, J Innate Immun, 4, 337, 10.1159/000336619
McCormick, 2010, Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity, Periodontol 2000, 54, 195, 10.1111/j.1600-0757.2010.00373.x
Quiñones-Mateu, 2003, Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication, AIDS, 17, F39, 10.1097/00002030-200311070-00001
Weinberg, 2006, Role of human β-defensins in HIV infection, Adv Dent Res, 19, 42, 10.1177/154407370601900109
Tugizov, 2011, HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells, Virology, 409, 211, 10.1016/j.virol.2010.10.004
Zapata, 2008, Increased levels of human β-defensins mRNA in sexually HIV-1 exposed but uninfected individuals, Curr HIV Res, 6, 531, 10.2174/157016208786501463
Niyonsaba, 2007, Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines, J Invest Dermatol, 127, 594, 10.1038/sj.jid.5700599
Varoga, 2005, Human β-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors, Arthritis Rheum, 52, 1736, 10.1002/art.21090
Sørensen, 2005, Differential regulation of β-defensin expression in human skin by microbial stimuli, J Immunol, 174, 4870, 10.4049/jimmunol.174.8.4870
Kutteh, 1996, Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation, Clin Exp Immunol, 104, 538, 10.1046/j.1365-2249.1996.36742.x
Bouman, 2005, Sex hormones and the immune response in humans, Hum Reprod Update, 11, 411, 10.1093/humupd/dmi008
Kaushic, 1998, Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response, Infect Immun, 66, 893, 10.1128/IAI.66.3.893-898.1998
Franklin, 1999, Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones, J Reprod Immunol, 42, 93, 10.1016/S0165-0378(98)00086-2
Klinger, 2000, A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system, Gynecol Endocrinol, 14, 15, 10.3109/09513590009167655
Masson, 2015, Genital inflammation and the risk of HIV acquisition in women, Clin Infect Dis, 61, 260, 10.1093/cid/civ298
Passmore, 2016, Genital inflammation, immune activation and risk of sexual HIV acquisition, Curr Opin HIV AIDS, 11, 156, 10.1097/COH.0000000000000232
Africander, 2011, Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract, Contraception, 84, 423, 10.1016/j.contraception.2011.06.006
Rollenhagen, 2011, Enhanced HIV-1 replication in ex vivo ectocervical tissues from post-menopausal women correlates with increased inflammatory responses, Mucosal Immunol, 4, 671, 10.1038/mi.2011.34
Guthrie, 2015, Depot medroxyprogesterone acetate use is associated with elevated innate immune effector molecules in cervicovaginal secretions of HIV-1-uninfected women, J Acquir Immune Defic Syndr, 69, 1, 10.1097/QAI.0000000000000533
Kurman, 2000, Norethindrone acetate and estradiol-induced endometrial hyperplasia, Obstet Gynecol, 96, 373
Eschenbach, 2000, Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium, Contraception, 62, 107, 10.1016/S0010-7824(00)00155-4
Kaushic, 2010, HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment, Am J Reprod Immunol, 63, 566, 10.1111/j.1600-0897.2010.00843.x
Blaskewicz, 2011, Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia, Biol Reprod, 85, 97, 10.1095/biolreprod.110.090423
Birse, 2017, Genital injury signatures and microbiome alterations associated with depot medroxyprogesterone acetate usage and intravaginal drying practices, J Infect Dis, 215, 590
Saba, 2013, Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle, Mucosal Immunol, 6, 1081, 10.1038/mi.2013.2
Neidleman, 2017, Mucosal stromal fibroblasts markedly enhance HIV infection of CD4+ T cells, PLoS Pathog, 13, e1006163, 10.1371/journal.ppat.1006163
Birse, 2015, Molecular signatures of immune activation and epithelial barrier remodeling are enhanced during the luteal phase of the menstrual cycle: implications for HIV susceptibility, J Virol, 89, 8793, 10.1128/JVI.00756-15
Mirmonsef, 2014, Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH, PLoS One, 9, e102467, 10.1371/journal.pone.0102467
Hummelen, 2010, Deep sequencing of the vaginal microbiota of women with HIV, PLoS One, 5, e12078, 10.1371/journal.pone.0012078
Anukam, 2006, Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis, Microbes Infect, 8, 2772, 10.1016/j.micinf.2006.08.008
Ravel, 2011, Vaginal microbiome of reproductive-age women, Proc Natl Acad Sci USA, 108, 4680, 10.1073/pnas.1002611107
Spear, 2008, Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis, J Infect Dis, 198, 1131, 10.1086/591942
Rampersaud, 2012, Microbiota of the upper and lower genital tract, Semin Fetal Neonatal Med, 17, 51, 10.1016/j.siny.2011.08.006
Watts, 2005, Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women, J Infect Dis, 191, 1129, 10.1086/427777
Cherpes, 2003, Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis, Clin Infect Dis, 37, 319, 10.1086/375819
Myer, 2005, Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study, J Infect Dis, 192, 1372, 10.1086/462427
Sha, 2005, Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis, J Infect Dis, 191, 25, 10.1086/426394
Cherpes, 2005, Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization, Clin Infect Dis, 40, 1422, 10.1086/429622
Achilles, 2013, The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota, AIDS, 27, S5, 10.1097/QAD.0000000000000058
Cohen, 2012, Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples, PLoS Med, 9, e1001251, 10.1371/journal.pmed.1001251
Anahtar, 2015, Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract, Immunity, 42, 965, 10.1016/j.immuni.2015.04.019
Borgdorff, 2016, Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier, Mucosal Immunol, 9, 621, 10.1038/mi.2015.86
Gareau, 2010, Probiotics and the gut microbiota in intestinal health and disease, Nat Rev Gastroenterol Hepatol, 7, 503, 10.1038/nrgastro.2010.117
Karimi, 2009, Lactobacillus reuteri–induced regulatory T cells protect against an allergic airway response in mice, Am J Respir Crit Care Med, 179, 186, 10.1164/rccm.200806-951OC
Karimi, 2012, A Lactobacillus rhamnosus strain induces a heme oxygenase dependent increase in Foxp3+ regulatory T cells, PLoS One, 7, e47556, 10.1371/journal.pone.0047556
Mirmonsef, 2011, The effects of commensal bacteria on innate immune responses in the female genital tract, Am J Reprod Immunol, 65, 190, 10.1111/j.1600-0897.2010.00943.x
Mirmonsef, 2012, Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with Toll-like receptor ligands, Am J Reprod Immunol, 67, 391, 10.1111/j.1600-0897.2011.01089.x
Doerflinger, 2014, Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner, J Infect Dis, 209, 1989, 10.1093/infdis/jiu004
Rebbapragada, 2008, Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment, J Acquir Immune Defic Syndr, 49, 520, 10.1097/QAI.0b013e318189a7ca
Vodstrcil, 2013, Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis, PLoS One, 8, e73055, 10.1371/journal.pone.0073055
Borgdorff, 2015, The impact of hormonal contraception and pregnancy on sexually transmitted infections and on cervicovaginal microbiota in african sex workers, Sex Transm Dis, 42, 143, 10.1097/OLQ.0000000000000245
Donders, 2017, Influence of contraceptive choice on vaginal bacterial and fungal microflora, Eur J Clin Microbiol Infect Dis, 36, 43, 10.1007/s10096-016-2768-8
Brooks, 2017, Changes in vaginal community state types reflect major shifts in the microbiome, Microb Ecol Health Dis, 28, 1303265, 10.1080/16512235.2017.1303265
Brooks, 2017, Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome, Contraception, 95, 405, 10.1016/j.contraception.2016.11.006
De Seta, 2012, Effects of hormonal contraception on vaginal flora, Contraception, 86, 526, 10.1016/j.contraception.2012.02.012
van de Wijgert, 2013, P3.221 Oral and injectable hormonal contraception decrease risk of bacterial vaginosis but oral contraception may increase risk of vaginal candidiasis: a systematic review of published and unpublished data, Sex Transm Infect, A217
Segall-Gutierrez, 2012, Effect of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women, Contraception, 86, 739, 10.1016/j.contraception.2012.05.148
Ishida, 2008, Effect of progestins with different glucocorticoid activity on bone metabolism, Clin Endocrinol (Oxf), 68, 423, 10.1111/j.1365-2265.2007.03059.x
Chi, 1993, What we have learned from recent IUD studies: a researcher’s perspective, Contraception, 48, 81, 10.1016/0010-7824(93)90001-N
Sheppard, 1987, Endometrial morphological changes in IUD users: a review, Contraception, 36, 1, 10.1016/0010-7824(87)90057-6
Shobokshi, 2002, Cervical mucus granulocyte macrophage colony stimulating factor and interleukin-2 soluble receptor in women using copper intrauterine contraceptive devices, Contraception, 66, 129, 10.1016/S0010-7824(02)00331-1
Ammälä, 1995, Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium, Fertil Steril, 63, 773, 10.1016/S0015-0282(16)57480-9
Woolley, 1996, Raised circulating levels of interleukin-6 in women with an intrauterine contraceptive device, Gynecol Obstet Invest, 42, 241, 10.1159/000291972
Lahey, 2012, Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract, PLoS One, 7, e38100, 10.1371/journal.pone.0038100
Baeten, 2005, Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort, J Acquir Immune Defic Syndr, 38, S18, 10.1097/01.qai.0000167030.18278.0e
Stringer, 2007, A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus, Am J Obstet Gynecol, 197, 144.e1, 10.1016/j.ajog.2007.03.031
Mellors, 1996, Prognosis in HIV-1 infection predicted by the quantity of virus in plasma, Science, 272, 1167, 10.1126/science.272.5265.1167
Lavreys, 2006, Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women, Clin Infect Dis, 42, 1333, 10.1086/503258
Stringer, 2009, HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial, AIDS, 23, 1377, 10.1097/QAD.0b013e32832cbca8
Cejtin, 2003, Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women, AIDS, 17, 1702, 10.1097/00002030-200307250-00019
Mostad, 1997, Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina, Lancet, 350, 922, 10.1016/S0140-6736(97)04240-2
Phillips, 2016, The safety of hormonal contraceptives for women living with HIV and their sexual partners, Contraception, 93, 11, 10.1016/j.contraception.2015.10.002
Polis, 2013, Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence, AIDS, 27, 493, 10.1097/QAD.0b013e32835ad539
Phillips, 2013, Effect of hormonal contraceptive methods on HIV disease progression: a systematic review, AIDS, 27, 787, 10.1097/QAD.0b013e32835bb672
Lawn, 2001, Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection, Clin Microbiol Rev, 14, 753, 10.1128/CMR.14.4.753-777.2001
Wang, 2004, The effect of hormonal contraception on genital tract shedding of HIV-1, AIDS, 18, 205, 10.1097/00002030-200401230-00009
Clemetson, 1993, Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya, JAMA, 269, 2860, 10.1001/jama.1993.03500220046024
Heffron, 2012, Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study, Lancet Infect Dis, 12, 19, 10.1016/S1473-3099(11)70247-X
Gisselquist, 2012, Use of hormonal contraceptives and risk of HIV-1 transmission, Lancet Infect Dis, 12, 510, 10.1016/S1473-3099(12)70115-9
Jain, 2012, Hormonal contraception and HIV acquisition risk: implications for individual users and public policies, Contraception, 86, 645, 10.1016/j.contraception.2012.03.008